Published in Neuroimmunomodulation on January 01, 2000
Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07
Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol Motil (2013) 1.04
Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphat Res Biol (2010) 0.91
Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain. Arthritis Res Ther (2010) 0.86
Changes in the immune system in depression and dementia: causal or coincidental effects? Dialogues Clin Neurosci (2006) 0.84
Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression? Curr Neuropharmacol (2012) 0.81
Psychiatric side effects of medications prescribed in internal medicine. Dialogues Clin Neurosci (2003) 0.75
Influence of the olfactory bulbs on blood leukocytes and behavioral responses to infection in Siberian hamsters. Brain Res (2009) 0.75
The minimally conscious state: definition and diagnostic criteria. Neurology (2002) 9.67
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med (1995) 7.21
High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc (1992) 3.12
Standardized assessment of concussion (SAC): on-site mental status evaluation of the athlete. J Head Trauma Rehabil (1998) 2.78
The projections of cells in different layers of the cat's visual cortex. J Comp Neurol (1975) 2.00
Hyperglycemic crises in urban blacks. Arch Intern Med (1997) 1.93
Standardized assessment of concussion in football players. Neurology (1997) 1.87
Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol (1993) 1.82
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol (1999) 1.73
Cell structure and function in the visual cortex of the cat. J Physiol (1974) 1.66
The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther (1997) 1.61
Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia (1997) 1.49
The effects of some hallucinogenic drugs upon the metabolism of noradrenaline. Life Sci (1969) 1.46
The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.44
Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci (1998) 1.44
Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther (1993) 1.38
Social isolation in the young rat: neurochemical effects of treatment with a long-acting neuroleptic, alpha-flupenthixol decanoate [proceedings]. Br J Pharmacol (1978) 1.38
Safety of amoxapine. Lancet (1989) 1.37
In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis. Antimicrob Agents Chemother (1985) 1.30
Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol (1979) 1.28
Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain. Psychopharmacologia (1974) 1.26
Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ (1998) 1.20
Management of airway trauma. I: Tracheobronchial injuries. Ann Thorac Surg (1985) 1.19
Traumatic brain injury and concussion in sports. JAMA (1999) 1.19
Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry (2009) 1.16
Fatal endotoxic shock of biliary tract origin complicating transhepatic cholangiography. Br Med J (1973) 1.15
Coffee drinking and nonfatal myocardial infarction in men under 55 years of age. Am J Epidemiol (1988) 1.14
Rodent models of alcoholism: a review. Alcohol Alcohol (1989) 1.14
Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat. Br J Pharmacol (1971) 1.14
Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect Immun (1996) 1.11
Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med (1985) 1.10
Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl (1996) 1.04
Stimulation by alcohols of cyclic AMP metabolism in human leukocytes. Possible role of cyclic AMP in the anti-inflammatory effects of ethanol. J Clin Invest (1977) 1.04
Acute thrombocytopenic purpura in relation to the use of drugs. Blood (1993) 1.04
Formation of thromboxane B2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA. J Immunol (1979) 1.04
Methanol intoxication with putaminal and white matter necrosis: MR and CT findings. AJNR Am J Neuroradiol (1995) 1.03
The specification of the retino-tectal projection in the chick. J Comp Neurol (1974) 1.03
An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience (1998) 1.03
Effects of arachidonic acid and other unsaturated fatty acids on mitogenesis in human lymphocytes. J Immunol (1979) 1.03
Macrophage activation and innate resistance to infection in SCID mice. Immunobiology (1994) 1.01
Laminar connections of the cat's auditory cortex. Brain Res (1981) 1.00
Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol Ther (1990) 1.00
The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain. Life Sci (1969) 0.98
Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol (1996) 0.98
Release of arachidonic acid from human lymphocytes in response to mitogenic lectins. J Exp Med (1979) 0.98
Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells. Infect Immun (1994) 0.98
Toxicity of antidepressants. Lancet (1986) 0.96
Changes in brain monoamine metabolism associated with CO2-induced amnesia in rats. Br J Pharmacol (1973) 0.95
Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol (1981) 0.94
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci (1999) 0.94
The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain. Arch Int Pharmacodyn Ther (1973) 0.94
The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry (2006) 0.94
The effect of a tetracyclic antidepressant compound, Org GB94, on the turnover of biogenic amines in rat brain. Biochem Pharmacol (1976) 0.94
Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord (1994) 0.93
Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology (1998) 0.92
Effects of acute injury characteristics on neuropsychological status and vocational outcome following mild traumatic brain injury. Brain Inj (1999) 0.91
An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology (2000) 0.91
Neutrophil and monocyte phagocytosis in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.91
Effect of four amphetamines on brain biogenic amines and their metabolites. Biochem Pharmacol (1972) 0.91
Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation. Behav Brain Res (1998) 0.91
Transient painful osteoporosis of the lower extremities. J Bone Joint Surg Am (1973) 0.90
Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacol Biochem Behav (1997) 0.90
Androgenic involvement in conditioned taste aversion. Horm Behav (1978) 0.89
Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action. Eur J Pharmacol (2000) 0.89
Research based recommendations on management of sport related concussion: summary of the National Athletic Trainers' Association position statement. Br J Sports Med (2006) 0.89
Development of the spatio-chromatic visual evoked potential (VEP): a longitudinal study. Vision Res (1998) 0.88
The effect of some hallucinogenic drugs on the amino acid precursors of brain monoamines. Life Sci I (1970) 0.88
Effect of level and duration of dietary n-3 polyunsaturated fatty acid supplementation on the transcriptional regulation of Delta9-desaturase in muscle of beef cattle. J Anim Sci (2008) 0.88
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol Biochem Behav (1995) 0.88
Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.88
Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiol Behav (2000) 0.88
Esophageal replacement with colon in children: functional results and long-term growth. Ann Thorac Surg (1983) 0.87
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. J Psychopharmacol (1997) 0.87
Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings]. Br J Pharmacol (1977) 0.87
Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacol Biochem Behav (1999) 0.87
Toward an understanding of violence: neurobehavioral aspects of unwarranted physical aggression: Aspen Neurobehavioral Conference consensus statement. Neuropsychiatry Neuropsychol Behav Neurol (2001) 0.87
Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol (1999) 0.86
Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett (2005) 0.86
Community-based exercise intervention: Zuni Diabetes Project. Diabetes Care (1988) 0.86
Behavioural, biochemical and histological effects of trimethyltin (TMT) induced brain damage in the rat. Neurochem Int (1992) 0.86
Peripheral adrenoceptors and serotonin receptors in depression. Changes associated with response to treatment with trazodone or amitriptyline. J Affect Disord (1985) 0.86
BIMT 17: a putative antidepressant with a fast onset of action? Psychopharmacology (Berl) (1997) 0.86
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Brain Behav Immun (2011) 0.86
Effects of prior exposure on conditioned taste aversion in the rat: androgen- and estrogen-dependent events. J Comp Physiol Psychol (1979) 0.86
Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology (2003) 0.86
Studies on the development of the chick optic tectum. 3. Effects of early eye removal. Brain Res (1972) 0.85
Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity. Eur Neuropsychopharmacol (1999) 0.85
Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. J Psychopharmacol (2007) 0.85